CID 71301017

(3-alpha,16-alpha)-eburnamenin-14(15h)-one oxime hydrochloride

Structural Information

Molecular Formula
C19H23N3O
SMILES
CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4/C(=N\O)/C2
InChI
InChI=1S/C19H23N3O/c1-2-19-9-5-10-21-11-8-14-13-6-3-4-7-15(13)22(16(12-19)20-23)17(14)18(19)21/h3-4,6-7,18,23H,2,5,8-12H2,1H3/b20-16-/t18-,19+/m1/s1
InChIKey
HPVDZBKXWQJQRP-FVQWEEDQSA-N
Compound name
(NZ)-N-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-ylidene]hydroxylamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

309.1841 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 310.19138 171.3
[M+Na]+ 332.17332 178.3
[M-H]- 308.17682 173.3
[M+NH4]+ 327.21792 191.1
[M+K]+ 348.14726 171.8
[M+H-H2O]+ 292.18136 161.3
[M+HCOO]- 354.18230 183.6
[M+CH3COO]- 368.19795 180.6
[M+Na-2H]- 330.15877 177.1
[M]+ 309.18355 169.4
[M]- 309.18465 169.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.